Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.20

-0.13 (-3.00%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +186.0% upside

Low Target $8.14

Average Target $12.01

High Target $13.09

Current Price $4.20

Current
$4.20

Target
$12.01

$8.14 $12.01 avg $13.09

Scenario Analysis

Bear Case

$8.14

93.8%

Low target

Base Case

$12.01

+186.0%

Avg target

Bull Case

$13.09

+211.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.75

-45.8% from high

52-Week Low

$2.90

+44.8% from low

Target vs 52W High

$12.01

+55.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%